A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection

References

1. Arthur J., Efstathiou S., Simmons A. 1993; Intranuclear foci containing low abundance herpes simplex virus latency-associated transcripts visualized by non-isotopic in situ hybridization. Journal of General Virology 74:1363–1370
   [Google Scholar]
2. Balan P., Davis-Poynter N., Bell S., Atkinson H., Browne H., Minson T. 1994; An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoprotein gG, gE, gl or the putative gj. Journal of General Virology 75:1245–1258
   [Google Scholar]
3. Bell S. P., Jantzen H. M., Tjian R. 1990; Assembly of alternative multiprotein complexes directs rRNA promoter selectivity. Genes & Development 4:943–954
   [Google Scholar]
4. Block T. M., Spivack J. G., Steiner I., Deshmane S., McIntosh M. T., Lirette R. P., Fraser N. W. 1990; A herpes simplex virus type 1 latency associated transcript mutant reactivates with normal kinetics from latent infection. Journal of Virology 64:3417–3426
   [Google Scholar]
5. Bloom D. C., Maidment N. T., Tan A., Dissette V. B., Feldman L. T., Stevens J. G. 1995; Long-term expression of a reporter gene from latent herpes simplex virus in rat hippocampus. Molecular Brain Research 31:48–60
   [Google Scholar]
6. Ecob-Prince M. S., Hassan K., Preston C. M. 1995; Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1. Journal of General Virology 76:1527–1532
   [Google Scholar]
7. Efstathiou S., Minson A. C. 1995; Herpes virus-based vectors. In British Medical Bulletin - Gene Therapy pp 45–55 Edited by Lever A. M. L., Goodfellow P. London: Churchill Livingstone;
   [Google Scholar]
8. Efstathiou S., Minson A. C., Field H. J., Anderson J. R., Wildy P. 1986; Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. Journal of Virology 57:446–455
   [Google Scholar]
9. Forrester A., Farrell H., Wilkinson G., Kaye J., Davis-Poynter N., Minson T. 1992; Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. Journal of Virology 66:341–348
   [Google Scholar]
10. Franke C. A., Hruby D. E. 1987; Quantitative assay of recombinant vaccinia virus-encoded neomycin phosphotransferase in infected eukaryotic cell lysates. Journal of Virological Methods 16:147–154
    [Google Scholar]
11. Glorioso J. C., Goins W. F., Fink D. J. 1992; Herpes simplex virus- based vectors. Seminars in Virology 3:265–276
    [Google Scholar]
12. Glorioso J. C., De Luca N. A., Fink D. J. 1995; Development and application of herpes simplex virus vectors for human gene therapy. Annual Review of Microbiology 49:675–710
    [Google Scholar]
13. Grummt I., Skinner J. A. 1985; Efficient transcription of a proteincoding gene from the RNA polymerase I promoter in transfected cells. Proceedings of the National Academy of Sciences, USA 82:722–726
    [Google Scholar]
14. Hill T. J., Field H. J., Blyth W. A. 1975; Acute and recurrent infection with herpes simplex virus in the mouse - a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
    [Google Scholar]
15. Hill J. M., Sedarati F., Javier R. T., Wagner E. K., Stevens J. G. 1990; Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117–125
    [Google Scholar]
16. Ho D. Y. 1992; Herpes simplex virus latency: molecular aspects. In Progress in Medical Virology pp 76–115 Edited by Melnick J. L. Basel: Karger;
    [Google Scholar]
17. Lokensgard J. R., Bloom D. C., Dobson A. T., Feldman L. T. 1994; Long-term promoter activity during herpes simplex virus latency. Journal of Virology 68:7148–7158
    [Google Scholar]
18. Lopata M. A., Cleveland D. W., Sollner-Webb B. 1986; RNA polymerase specificity of mRNA production and enhancer action. Proceedings of the National Academy of Sciences, USA 83:6677–6781
    [Google Scholar]
19. McGeoch D. J., Cunningham C., McIntyre G., Dolan A. 1991; Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. Journal of General Virology 72:3057–3075
    [Google Scholar]
20. Palmer T. D., Miller A. D., Reeder R. H., McStay B. 1993; Efficient expression of a protein coding gene under the control of an RNA polymerase I promoter. Nucleic Acids Research 21:3451–3457
    [Google Scholar]
21. Reeder R. H., Sollner-Webb B., Wahn H. L. 1977; Sites of transcription initiation in vivo on Xenopus laevis ribosomal DNA. Proceedings of the National Academy of Sciences, USA 74:5402–5406
    [Google Scholar]
22. Rock D. L., Fraser N. W. 1983; Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302:523–525
    [Google Scholar]
23. Roizman B., Sears A. E. 1996; Herpes simplex viruses and their replication. In Fields Virology pp 2231–2295 Edited by Field B. M. Knipe D. M., Howley P. M. Philadelphia: Lippincott-Raven;
    [Google Scholar]
24. Smale S. T., Tjian R. 1985; Transcription of herpes simplex virus tk sequences under the control of wild-type and mutant human RNA polymerase I promoters. Molecular and Cellular Biology 5:352–362
    [Google Scholar]
25. Stevens J. G., Wagner E. K., Devi-Rao G. B., Cook M. L., Feldman L. T. 1987; RNA complementary to a herpes alpha gene mRNA is prominent in latently infected neurones. Science 235:1056–1059
    [Google Scholar]
26. Stow -N. D., Wilkie N. M. 1976; An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA. Journal of General Virology 33:447–458
    [Google Scholar]
27. Wilkinson G. W., Akrigg G. 1992; Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus. Nucleic Acids Research 202233–2239
    [Google Scholar]